Showing results (1971-1980 of 2,168) with videos related to

Sort By:
Pageof 217
Clinical and Translational Medicine|October 5, 2024
N6-methyladenosine-mediated upregulation of LNCAROD confers radioresistance in esophageal squamous cell carcinoma through stabilizing PARP1Xiaobo Shi, Xiaozhi Zhang, Xinran Huang, et al.
Seizure|April 21, 2015
A functional polymorphism of the microRNA-146a gene is associated with susceptibility to drug-resistant epilepsy and seizures frequencyLili Cui, Hua Tao, Yan Wang, et al.
Environmental Research|May 7, 2023
Challenges and engineering application of landfill leachate concentrate treatmentQian Li, Hanlin Cui, Yihao Li, et al.
Fitoterapia|November 28, 2016
New monoterpenoid oxindole alkaloid derivatives from the stems of Uncaria hirsuta Havil. and their cytotoxicity and tandem mass spectrometric fragmentationHui-Qin Pan, Wen-Zhi Yang, Dan Zhao, et al.
European Journal of Translational Myology|May 26, 2026
Risk factors and critical thresholds for glucocorticoid-induced ocular adverse reactions in children: implications for muscle and neuromuscular disease managementYou Li, Tingxin Cui, Zhilang Lin, et al.
Journal of Autoimmunity|July 1, 2019
Cytotoxic KLRG1 expressing lymphocytes invade portal tracts in primary biliary cholangitisYikang Li, Bo Li, Zhengrui You, et al.
Cancer Management and Research|June 5, 2020
Predictive Factors for Level V Lymph Node Metastases in Papillary Thyroid Carcinoma with BRAF Mutation and Clinicopathological FeaturesGui-You Li, Hai-Long Tan, Pei Chen, et al.
Frontiers in Endocrinology|September 8, 2022
Factors correlated with targeted prevention for prediabetes classified by impaired fasting glucose, impaired glucose tolerance, and elevated HbA1c: A population-based longitudinal studyXiaoyue Zhu, Zhipeng Yang, Zhiliang He, et al.
Lipids in Health and Disease|December 6, 2022
Association between combined exposure to plasma heavy metals and dyslipidemia in a chinese populationTingyu Luo, Shiyi Chen, Jiansheng Cai, et al.
Signal Transduction and Targeted Therapy|July 14, 2024
SHR-A1811 (antibody-drug conjugate) in advanced HER2-mutant non-small cell lung cancer: a multicenter, open-label, phase 1/2 studyZiming Li, Zhengbo Song, Wei Hong, et al.
Pageof 217